Mode
Text Size
Log in / Sign up

mavacamten

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of mavacamten

8 trials tracked of mavacamten: 4 in phase 3 or 4 and 3 with published results. The most-cited published study has 171 citations.

8Trials tracked
4Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 3 4 Phase 2 3 Phase 1 1
  1. Phase 3 A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy Completed · 171 cited
  2. Phase 3 A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM Completed · 116 cited
  3. Phase 3 Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Completed · 106 cited
  4. Phase 3 A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy Completed
  5. Phase 2 A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT Completed
  6. Phase 2 Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER Completed
Show 2 more trials
  1. Phase 2 A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) Completed
  2. Phase 1 Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.